Heightened Drug Pricing Scrutiny Now A Factor In Analysts Views Of Impax Labs, Concordia International

By: via Benzinga
There is “heightened drug pricing scrutiny across the US and UK,” Goldman Sachs’ Stephan Stewart said in a report. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.